SCHEMBL29566333

SCHEMBL29566333

CN1CCC(c2ccc(Oc3nc(NS(=O)(=O)c4cnn(C)c4)nc(-c4ccccc4)c3CC(F)(F)F)cc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 6/20 0.37
▸ HTR7 P34969 6/20 0.37
▸ SLC8A1 P32418 1/20 0.35
▸ MAP4K1 Q92918 3/20 0.35
▸ MMP3 P08254 1/20 0.35
▸ EGFR P00533 2/20 0.34
▸ CCNT1 O60563 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CDK4 P11802 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CCND3 P30281 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CCNH P51946 1/20 0.34
▸ MNAT1 P51948 1/20 0.34
▸ CDK6 Q00534 1/20 0.34
▸ MAP4K3 Q8IVH8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309454 1.00 HTR1A (0.37) HTR1AHTR7SLC8A1MAP4K1MMP3
SCHEMBL24310081 0.91 BRD4 (0.35) HTR1AHTR7SLC8A1MMP3CCNT1
SCHEMBL29567168 0.91 BRD4 (0.35) HTR1AHTR7SLC8A1MMP3CCNT1
SCHEMBL24309455 0.90 BRD4 (0.37) HTR1AHTR7SLC8A1MAP4K1CCNT1
SCHEMBL24309452 0.89 HTR1A (0.39) HTR1AHTR7SLC8A1MMP3CDK4
SCHEMBL29567027 0.88 BRD4 (0.35) HTR1AHTR7SLC8A1MAP4K1MMP3
SCHEMBL24309451 0.88 BRD4 (0.35) HTR1AHTR7SLC8A1MAP4K1MMP3
SCHEMBL24309960 0.88 PTK2 (0.32) HTR1AHTR7SLC8A1MAP4K1BRD4
SCHEMBL24309964 0.87 TNK2 (0.34) SLC8A1MAP4K1CCNT1CDK1CDK4
SCHEMBL24309772 0.82 HTR1A (0.35) HTR1AHTR7SLC8A1CCNT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback